Melanoma UK is pleased to share the Talking About Melanoma Matters Discussion Guide, which has been published by the pharmaceutical company Bristol-Myers Squibb.

 

As treatment options have changed in recent years, patients with melanoma now have more choices to make about their treatment and care.  These choices can be complex, and it is important that patients have all the information and support they need to make fully informed decisions.

To support improvements in the conversations that take place between patients and their healthcare professionals, at the point of referral, diagnosis, treatment and living beyond melanoma, Melanoma UK was invited by Bristol-Myers Squibb to help set out some guiding principles for communicating well.

These guiding principles have been largely informed by the experiences of over 100 patients with melanoma, who responded to a survey conducted for the Melanoma Patients Matter project, on the information and support provided to them. 

Melanoma UK has also made contributions to these, based on our experiences of supporting patients with melanoma.

Click to read the full Talking About Melanoma Matters - Discussion Guide 

The project was initiated and funded by Bristol-Myers Squibb, while Melanoma UK has provided experience and expertise in shaping the project and resulting Discussion Guide, alongside the British Association of Skin Cancer Specialist Nurses (BASCSN), Melanoma Action and Support Scotland (MASScot) and Melanoma Focus.